Next Science (ASX:NXS) Accounts Payable : A$2.11 Mil (As of Dec. 2023)

View and export this data going back to 2019. Start your Free Trial

What is Next Science Accounts Payable?

Next Science's Accounts Payable for the quarter that ended in Dec. 2023 was A$2.11 Mil.

Next Science's quarterly Accounts Payable increased from Dec. 2022 (A$1.44 Mil) to Jun. 2023 (A$4.95 Mil) but then declined from Jun. 2023 (A$4.95 Mil) to Dec. 2023 (A$2.11 Mil).

Next Science's annual Accounts Payable increased from Dec. 2021 (A$0.72 Mil) to Dec. 2022 (A$1.44 Mil) and increased from Dec. 2022 (A$1.44 Mil) to Dec. 2023 (A$2.11 Mil).

Next Science Accounts Payable Historical Data

The historical data trend for Next Science's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Next Science Accounts Payable Chart

Next Science Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable

Get a 7-Day Free Trial

0.91

0.76

0.72

1.44

2.11

Next Science Semi-Annual Data
	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Accounts Payable	Get a 7-Day Free Trial					0.72	2.91	1.44	4.95	2.11

Next Science Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.

Next Science Accounts Payable Related Terms

Thank you for viewing the detailed overview of Next Science's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Next Science (ASX:NXS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Next Science Ltd (ASX:NXS) » Definitions » Accounts Payable

Comparable Companies

Traded in Other Exchanges

NXSCF:USA

Address

821 Pacific Highway, Suite 1902, Level 19, Tower A, The Zenith Building, Chatswood, NSW, AUS, 2067

Website

https://www.nextscience.com

Next Science Ltd is a medical technology company. It is engaged in the development and commercialization of its proprietary Xbio technology to reduce the impact of biofilm-based infections in human health. Xbio is a non-toxic technology with proven efficacy in eradicating both biofilm based and free-floating bacteria. Its products include Bactisure, SURGX, XEPERIENCE and BLASTX. The company derives revenue from the U.S. and Australia, of which prime revenue is derived from the U.S.

Next Science (ASX:NXS) Headlines

No Headlines